Skip to main content
MGRX
NASDAQ Energy & Transportation

Nuclea Energy Signs Definitive Reverse Merger with Mangoceuticals, Existing Shareholders to Hold Just 4%

Tom Rudovsky · Reported by TMX Newsfile
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.379
Mkt Cap
$6.505M
52W Low
$0.162
52W High
$2.75
52W Position info
134% above low
Off High info
86% below high
Rel. Volume info
6.3× avg
Market data snapshot near publication time

MGRX has more than doubled off its 52-week low of $0.162 on elevated volume (6.3× avg).

Summary

Nuclea Energy and Mangoceuticals have signed a definitive business combination agreement, advancing the reverse merger that will take the private nuclear startup public via Nasdaq. The deal gives Nuclea shareholders 96% of the combined company, leaving existing MGRX holders with just 4% — a massively dilutive outcome for current equity. The transaction is structured to close before stockholder and Nasdaq approvals, with a 19.99% cap on voting and economic rights until those approvals are secured. This follows the 8-K and 425 filings earlier today that first disclosed the planned merger, but the definitive agreement locks in terms and adds the unusual pre-approval closing mechanism. For a company with a going concern warning and a market cap under $7 million, the reverse merger represents a complete transformation into a nuclear energy play, though existing shareholders are nearly wiped out. The deal positions Nuclea to fund its Morpheus microreactor development amid surging AI-driven electricity demand.

At the time of this announcement, MGRX was trading at $0.38 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $6.5M. The 52-week trading range was $0.16 to $2.75. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: TMX Newsfile.


Price Chart

Share this article

Copied!

MGRX - Latest Insights

MGRX
Oct 09, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.430
Real-time Price: $0.190 info
Change: -$0.240 (-56%) info
Market Cap: $4.263M info
MGRX
Oct 09, 2026, 4:00 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $0.4251
Real-time Price: $0.190 info
Change: -$0.2351 (-55%) info
Market Cap: $4.263M info
MGRX
Oct 06, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.4107
Real-time Price: $0.190 info
Change: -$0.2207 (-54%) info
Market Cap: $4.263M info
MGRX
Oct 01, 2026, 3:50 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4921
Real-time Price: $0.190 info
Change: -$0.3021 (-61%) info
Market Cap: $4.263M info
MGRX
Aug 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.4021
Real-time Price: $0.190 info
Change: -$0.2121 (-53%) info
Market Cap: $4.263M info